Kotmale Holdings PLC (COSE:LAMB.N0000)

Intra-Cellular Therapies Revenue

In the fiscal year ending March 31, 2025, Kotmale Holdings had annual revenue of 10.16B LKR with 2.28% growth. Kotmale Holdings had revenue of 2.48B in the quarter ending March 31, 2025, with 3.50% growth.

• Revenue: 10.16B
• Revenue Growth: +2.28%
• P/S Ratio: 1.81
• Revenue / Employee: 74.71M
• Employees: 136
• Market Cap: 18.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	10.16B	226.42M	2.28%
Mar 31, 2024	9.93B	1.46B	17.27%
Mar 31, 2023	8.47B	4.13B	95.12%
Mar 31, 2022	4.34B	1.07B	32.77%
Mar 31, 2021	3.27B	377.13M	13.04%